Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Cleerly

Explore full profile

A digital healthcare company transforming the way clinicians approach the treatment of heart disease

Denver, United StatesFounded 2017Biotech & Life Sciences
Valuation $1–2.5B Last recorded · 2024
Headcount 100–500 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Cleerly and the history behind them.

About Cleerly

Cleerly Health is a digital healthcare startup that is revolutionizing the approach to treating heart disease. The company operates in the healthcare market, specifically focusing on cardiovascular care. It uses artificial intelligence (AI) to analyze coronary computed tomography angiography (CCTA) imaging, which is a type of heart scan. This allows clinicians to identify and define atherosclerosis, a condition where plaque builds up in the heart's arteries, at an earlier stage.

Cleerly Health's business model is centered around its AI-based digital care platform. This platform transforms complex imaging data into actionable insights, enabling clinicians to provide personalized treatment plans for their patients. The company's primary clients are healthcare providers, who use the platform to improve their clinical and financial outcomes.

The company's innovative approach allows for a more precise evaluation of heart disease, going beyond traditional measures by analyzing, characterizing, and quantifying types of plaque. This enables healthcare providers to more accurately determine a patient's risk of heart attack and develop a treatment plan to improve heart health.

Cleerly Health generates revenue by offering its digital cardiovascular care management program to healthcare providers. This program includes digital and print tools that transform complex imaging data into actionable clinical insights.

In summary, Cleerly Health is a digital healthcare startup that uses AI to help healthcare providers more accurately diagnose and treat heart disease, leading to improved patient outcomes and financial benefits for the providers.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2017
Headquarters
Denver, United States
Employees
354
Open positions
29
Dealroom signal
93.5/100
Industry
Health
Sub-industry
BioTechnology, Health Platform
Sector
Biotech & Life Sciences, Biotechnology, Drug Development, Medical Imaging, Core AI, Spinout, Rumoured $1B, Biotech and Pharma, AI for medical imaging, Techbio
Technology
Artificial Intelligence
Client focus
b2b

Funding history

7 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES COther financing Dec 2024 $106M $1.1B Battery Ventures · Insight Partners ↗
SERIES COther financing Jul 2022 $223M $892M Mirae Asset Capital · LRVHealth · Presight Capital · New Leaf Ventures ↗
Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

Cleerly website traffic

Latest recorded traffic for Cleerly is 27K monthly website visits, down 48.1% over the last three months. Cleerly's team grew 88.3% over the past year.

Latest monthly visits27K 3-month web change-48.1% 1-year team growth+88.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

23 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A9 investors entered at this stage

  • ImpactAssets
  • Esplanade Ventures
  • Cavendish Impact Capital
  • LRVHealth
  • DigiTx Partners
  • Cigna Ventures
  • New Leaf Venture Partners
  • American College of Cardiology
  • Vensana Capital

Series B and later12 investors entered at this stage

Other known investors2 additional known investors

  • New York Presbyterian Hospital
  • Weill Cornell Medicine
Team profiled 13 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States79.5%
🇵🇹 Portugal20.1%
🇳🇿 New Zealand0.4%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Cleerly on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Cleerly’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.